Hamilelikte imidazolidinone kullanmaktan kaçınmalı mıyım? | VeriMom
Animal reproduction data (multi‑generation / reproductive studies) report effects (reports / summaries cite reduced litter weights and reproductive NOAELs), and multiple safety data sheets / C&L inventory notifications list Repr.2 / H361 for 2‑imidazolidinone; however there is no harmonised CLH (no ECHA Annex VI H360) nor a formal CIR/SCCS opinion specific to CAS 120‑93‑4. Taken together this supports ‘suspected’ (h=2) but not confirmed teratogen status. (sources: ECHA substance pages / C&L notifications; literature summary of reproductive studies).
ECHA regulatory hazard statements
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- imidazolidinone hamilelikte güvenli mi?
- Animal reproduction data (multi‑generation / reproductive studies) report effects (reports / summaries cite reduced litter weights and reproductive NOAELs), and multiple safety data sheets / C&L inventory notifications list Repr.2 / H361 for 2‑imidazolidinone; however there is no harmonised CLH (no ECHA Annex VI H360) nor a formal CIR/SCCS opinion specific to CAS 120‑93‑4. Taken together this supports ‘suspected’ (h=2) but not confirmed teratogen status. (sources: ECHA substance pages / C&L notifications; literature summary of reproductive studies).
- imidazolidinone emzirirken güvenli mi?
- Same basis as pregnancy: animal reproduction findings and multiple supplier/SDS / C&L inventory notifications raising Repr.2 (H361) support a cautious classification of ‘suspected’ reproductive hazard. Direct data on lactational transfer or human breastfeeding outcomes were not located. Exposure via cosmetics expected to be low. (sources: supplier SDS / C&L notifications; literature summaries).
- imidazolidinone bebek cildi için güvenli mi?
- Hazard (h=2) carried over from animal reproductive effects and H361 notifications. No infant‑specific studies were found. Dermal exposure assessment/data (dermal absorption rates in adults or infants) were not located — cosmetic exposure is likely low so exposure score remains 0; infant dermal absorption was not demonstrably quantified in available sources. (sources: SDS / C&L inventory; literature summaries).
- VeriMom imidazolidinone nasıl puanlıyor?
- VeriMom imidazolidinone'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 39/100 (yüksek risk) olarak puanlar.
- Hamilelikte imidazolidinone yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.